The FDA has given Siemens the go ahead to bring to the U.S. its top end Artis Q and Artis Q.zen angiography systems. The devices, unveiled recently at RSNA in Chicago, feature the company’s latest X-ray tubes and detectors which together deliver the highest quality imaging, capable of spotting tiny vessels in the brain and heart during inverventional procedures.
The systems feature low radiation dose modes that allow for imaging at lower quality when the best is unnecessary.
More from the press release:
In the treatment of CAD, the new integrated IVUS (intravascular ultrasound) map application automatically and precisely co-registers IVUS images and angiography images, adding detailed IVUS data such as vessel, lumen, and wall structure. Additionally, CLEARstent Live allows the cardiologist to image stents with motion stabilization in real time by freezing motion in the region defined by the balloon markers.
Other new 3D applications are designed to image the smallest structures inside the head. Their high spatial resolution is crucial for imaging intracranial stents or other miniscule structures such as the cochlea of the inner ear. Moving organs such as the lungs can be imaged in 3D in less than three seconds, reducing motion artifacts and the required amount of contrast agent. Through visualization and measurement of blood volumes in the liver or other organs, Siemens’functional 3D imaging provides a basis for planning therapies such as chemo-embolization and hepatic tumors.
Product page: Artis Q and Artis Q.zen…
Press release: FDA Clears Siemens Angiography System Families